KD Logo

Taking a look at what insiders are doing to gauge the PTC Therapeutics Inc (PTCT)’s direction

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. PTC Therapeutics Inc shares valued at $83,669 were sold by Klein Matthew B. on Apr 19 ’24. At $24.89 per share, Klein Matthew B. sold 3,361 shares. The insider’s holdings dropped to 225,807 shares worth approximately $7.71 million following the completion of this transaction.

Also, Klein Matthew B. sold 1,307 shares, netting a total of over 32,851 in proceeds. Following the sale of shares at $25.14 each, the insider now holds 229,168 shares.

Before that, Pauwels Eric had sold 787 shares from its account. In a trade valued at $19,781, the CHIEF EXECUTIVE OFFICER traded PTC Therapeutics Inc shares for $25.14 each. Upon closing the transaction, the insider’s holdings decreased to 787 shares, worth approximately $2.31 million.

As published in a research note from Morgan Stanley on December 19, 2023, PTC Therapeutics Inc [PTCT] has been rated down from an Equal-weight to an Underweight and the price target has been revised to $28. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of October 30, 2023, Oppenheimer has increased its “Perform” rating to a “an Outperform” for PTCT. Earlier on October 27, 2023, Citigroup downgraded its rating. Their new recommendation was “a Sell” for PTCT stock which previously was a “a Neutral”.

Analyzing PTCT Stock Performance

During the last five days, there has been a surge of approximately 35.50%. Over the course of the year, PTC Therapeutics Inc shares have jumped approximately 23.95%. Shares of the company reached a 52-week high of $35.47 on 05/01/24 and a 52-week low of $23.58 on 02/13/24. A 50-day SMA is recorded $28.50, while a 200-day SMA reached $28.59. Nevertheless, trading volume fell to 1.1 million shares from 1.42 million shares the previous day.

Support And Resistance Levels for PTC Therapeutics Inc (PTCT)

According to the 24-hour chart, there is a support level at 32.08, which, if violated, would cause prices to drop to 30.01. In the upper region, resistance lies at 35.85. The next price resistance is at 37.55. RSI (Relative Strength Index) is 73.79 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 5.56, which suggests the price will increase in the coming days. Percent R is at 11.42%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular

[the_ad id="945"]